Coronary intervention in patients with diabetes, chronic renal disease, and the elderly: therapeutic implications

Area of Science:

• Cardiology
• Nephrology
• Endocrinology

Background:

• Percutaneous coronary intervention (PCI) carries risks.
• Certain patient groups, including those with diabetes mellitus, chronic renal disease, or advanced age, have elevated risks.
• These risks include both bleeding complications and thrombotic events.

Purpose of the Study:

• To review the clinical implications of comorbidities in patients undergoing PCI.
• To discuss current therapeutic strategies for managing bleeding and thrombosis risks in these specific patient populations.

Main Methods:

• Literature review of clinical studies and guidelines.
• Synthesis of evidence regarding risk factors and management strategies.

Main Results:

• Patients with diabetes mellitus, chronic renal disease, or advanced age represent a vulnerable group during PCI.
• These conditions significantly increase the likelihood of adverse bleeding and thrombotic events post-PCI.
• Therapeutic options require careful consideration to balance ischemic and bleeding risks.

Conclusions:

• Management of patients with diabetes, chronic renal disease, or advanced age undergoing PCI requires a tailored approach.
• Optimizing therapeutic strategies is crucial to mitigate the dual risks of bleeding and thrombosis in this population.